Literature DB >> 32984917

New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer.

D Gareth Evans1, Emma R Woodward2.   

Abstract

Entities:  

Keywords:  Breast cancer; Heritable TP53-related cancer; Li-fraumeni syndrome; MRI; Penetrance; Sarcoma; TP53; Variant

Year:  2021        PMID： 32984917     DOI： 10.1007/s10689-020-00207-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


× No keyword cloud information.
  47 in total

1.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

2.  TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.

Authors:  Uri Tabori; Adam Shlien; Berivan Baskin; Sarah Levitt; Peter Ray; Noa Alon; Cynthia Hawkins; Eric Bouffet; Malgorzata Pienkowska; Lucie Lafay-Cousin; Alexa Gozali; Nataliya Zhukova; Lisa Shane; Ignacio Gonzalez; Jonathan Finlay; David Malkin
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

3.  Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.

Authors:  Susanne Magnusson; David Gisselsson; Thomas Wiebe; Ulf Kristoffersson; Åke Borg; Håkan Olsson
Journal:  Pediatr Blood Cancer       Date:  2012-05-31       Impact factor: 3.167

4.  Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.

Authors:  Gaëlle Bougeard; Mariette Renaux-Petel; Jean-Michel Flaman; Camille Charbonnier; Pierre Fermey; Muriel Belotti; Marion Gauthier-Villars; Dominique Stoppa-Lyonnet; Emilie Consolino; Laurence Brugières; Olivier Caron; Patrick R Benusiglio; Brigitte Bressac-de Paillerets; Valérie Bonadona; Catherine Bonaïti-Pellié; Julie Tinat; Stéphanie Baert-Desurmont; Thierry Frebourg
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

5.  Childhood cancer and the SBLA syndrome.

Authors:  H T Lynch; H A Guirgis
Journal:  Med Hypotheses       Date:  1979-01       Impact factor: 1.538

6.  Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.

Authors:  D G R Evans; A Moran; R Hartley; J Dawson; B Bulman; F Knox; A Howell; F Lalloo
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

7.  Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.

Authors:  Kelly D Gonzalez; Katie A Noltner; Carolyn H Buzin; Dongqing Gu; Cindy Y Wen-Fong; Vu Q Nguyen; Jennifer H Han; Katrina Lowstuter; Jeffrey Longmate; Steve S Sommer; Jeffrey N Weitzel
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

8.  A cancer family syndrome in twenty-four kindreds.

Authors:  F P Li; J F Fraumeni; J J Mulvihill; W A Blattner; M G Dreyfus; M A Tucker; R W Miller
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

9.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Authors:  Simone Hettmer; Natasha M Archer; Gino R Somers; Ana Novokmet; Amy J Wagers; Lisa Diller; Carlos Rodriguez-Galindo; Lisa A Teot; David Malkin
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860
View more
  5 in total

Review 1.  Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma.

Authors:  Michael R Clay; Emilia M Pinto; Lauren Fishbein; Tobias Else; Katja Kiseljak-Vassiliades
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

2.  Revisiting the indication for prophylactic contralateral mastectomy in patients with Li-Fraumeni syndrome and breast cancer. Case report

Authors:  Ximena Briceño-Morales; Clara Briceño-Morales; Silvia Inés Guerrero-Macías; Ana María Pedroza-Durán; Raúl Alexis Súarez-Rodríguez
Journal:  Rev Colomb Obstet Ginecol       Date:  2021-09-30

3.  Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients.

Authors:  Abdul Khalid Siraj; Tariq Masoodi; Rong Bu; Sandeep Kumar Parvathareddy; Kaleem Iqbal; Saud Azam; Maha Al-Rasheed; Dahish Ajarim; Asma Tulbah; Fouad Al-Dayel; Khawla Sami Al-Kuraya
Journal:  Hered Cancer Clin Pract       Date:  2021-12-14       Impact factor: 2.857

4.  From BRCA1 to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes.

Authors:  Emma R Woodward; Elke M van Veen; D Gareth Evans
Journal:  Breast Care (Basel)       Date:  2021-03-31       Impact factor: 2.860

5.  Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study.

Authors:  Nathalie Rippinger; Christine Fischer; Hans-Peter Sinn; Nicola Dikow; Christian Sutter; Kerstin Rhiem; Sabine Grill; Friedrich W Cremer; Huu P Nguyen; Nina Ditsch; Karin Kast; Simone Hettmer; Christian P Kratz; Sarah Schott
Journal:  Cancer Med       Date:  2021-09-26       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.